SOLTEL

This brand name is authorized in Germany, Spain, United Kingdom

Active ingredients

The drug SOLTEL contains one active pharmaceutical ingredient (API):

1 Salmeterol UNII 6EW8Q962A5 - SALMETEROL XINAFOATE

Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist. These pharmacological properties of salmeterol offer more effective protection against histamine-induced bronchoconstriction and produce a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists. Read about Salmeterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOLTEL Pressurised inhalation, suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AC12	Salmeterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 11715357, 11715363
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 83247
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 335613